Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei

Neuroscience

Volumn 91, Issue 3, 1999, Pages 935-946

  Ruskin, D N ^a   Bergstrom, D A ^a   Mastropietro, C W ^a   Twery, M J ^a   Walters, J R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Apomorphine; D1 receptor; Entopeduncular nucleus; Fos; SKF 38393; Substantia nigra pars reticulata

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; BRAIN INJURY; CIRCLING BEHAVIOR; CORPUS STRIATUM; CORTICAL SYNCHRONIZATION; DOSE RESPONSE; ENTOPEDUNCULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NERVE CELL INHIBITION; NERVE CONDUCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TISSUE DISTRIBUTION;

ANIMALS; APOMORPHINE; BASAL GANGLIA; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE AGONISTS; ELECTROPHYSIOLOGY; HYPOTHALAMUS; MALE; NEURAL INHIBITION; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; STEREOTYPIC MOVEMENT DISORDER; SUBSTANTIA NIGRA; THALAMIC NUCLEI;

EID: 0032906176     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00689-7     Document Type: Article

References (56)

1. Albin R.L, Young A.B, Penney J.B The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. 1 receptor efficacy. Eur. J. Pharmac. 188:1990;335-347.
3. Bergstrom D.A, Bromley S.D, Walters J.R Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia. Eur. J. Pharmac. 100:1984;3-12.
4. Bhatia K.P, Marsden C.D The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 117:1994;859-876.
5. 2 agonists in intact rats. Brain Res. 504:1989;276-283.
6. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
7. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Expl Brain Res. 105:1995;48-58.
8. Cepeda C., Walsh J.P, Hull C.D, Howard S.G, Buchwald N.A, Levine M.S Dye-coupling in the neostriatum of the rat: I. Modulation by dopamine-depleting lesions. Synapse. 4:1989;229-237.
9. Cohen B. J., Clarkson T. B., Flynn R. J., Lang C. M., Melby E. C., Rabstein M. M., Soave O. A., Trum B. F. and Usenik E. A. (1985) Guide for the Care and Use of Animals, Department of Health, Education and Welfare, U. S. Government Printing Office.
10. DeLong M.R, Georgopoulos A.P Motor functions of the basal ganglia as revealed by studies of single cell activity in the behaving primate. Adv. Neurol. 24:1979;131-140.
11. Doucet J.-P., Nakabeppu Y., Bedard P.J, Hope B.T, Nestler E.J, Jasmin B.J, Chen J.-S., Iadarola M.J, St-Jean M., Wigle N., Blancher P., Grondin R., Robertson G.S Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of ΔFosB-like protein(s) in both the rodent and primate striatum. Eur. J. Neurosci. 8:1996;365-381.
12. Ernst A.M, Smelik P.G Site of action of dopamine and apomorphine on compulsive gnawing behavior in rats. Experientia. 22:1966;837-838.
13. 1-mediated turning behavior and striatal c-fos expression by the substantia nigra. Synapse. 19:1995;233-240.
14. Filion M. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res. 179:1979;425-441.
15. Filion M., Tremblay L., Bedard P.J Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;152-161.
16. Fuxe K., Fredholm B.B, Ogren S.O, Agnati L.F, Hokfelt T., Gustafsson J.A Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine. Acta Endocrinol. 216(Suppl.):1978;27-56.
17. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
18. Hikosaka O., Wurtz R.H Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of visual and auditory responses to saccades. J. Neurophysiol. 49:1983;1230-1253.
19. 1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. J. Pharmac. exp. Ther. 260:1992;409-416.
20. Huang K.-X., Walters J.R Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. J. Pharmac. exp. Ther. 271:1994;1434-1443.
21. Jiang H.-K., McGinty J.F, Hong J.S Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507:1990;57-64.
22. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 63:1994;363-379.
23. Joseph J.P, Boussaoud D. Role of the cat substantia nigra pars reticulata in eye and hand movements. I. Neural activity. Expl Brain Res. 57:1985;286-296.
24. Kaneoke Y., Vitek J.L Burst and oscillation as disparate neuronal properties. J. Neurosci. Meth. 68:1996;211-223.
25. Kilpatrick I.C, Starr M.S, Fletcher A., James T.A, MacLeod N.K Evidence for a GABAergic nigrothalamic pathway in the rat. Expl Brain Res. 40:1980;45-54.
26. Kozlowski M.R, Marshall J.F Rotation induced by intranigral injections of GABA agonists and antagonists: zone-specific effects. Pharmac. Biochem. Behav. 13:1980;561-567.
27. 1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience. 72:1996;863-876.
28. Kreiss D.S, Mastropietro C.W, Rawji S.S, Walters J.R The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 17:1997;6807-6819.
29. 2 synergism are unrelated to changes in striatal receptor density. Synapse. 12:1992;14-26.
30. 2 receptors mediate the behavioral effects of dopamine agonists. Behav. Brain Res. 38:1990;233-242.
31. MacLeod N.K, Ryman A., Arbuthnott G.W Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience. 38:1990;447-456.
32. Mendez J.S, Cotzias G.C, Finn B.W, Dahl K. Rotatory behavior induced in nigra-lesioned rats by N-propylnoraporphine, apomorphine, and levodopa. Life Sci. 16:1975;1737-1742.
33. Mink J.W The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50:1996;381-425.
34. Murer M.G, Riquelme L.A, Tseng K.Y, Pazo J.H Substantia nigra pars reticulata single unit activity in normal and 6-OHDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse. 27:1997;278-293.
35. Nauta J.W.H. A proposed conceptual reorganization of the basal ganglia and telencephalon. Neuroscience. 4:1979;1875-1881.
36. Nini A., Feingold A., Slovin H., Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of Parkinsonism. J. Neurophysiol. 74:1995;1800-1805.
37. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
38. 1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
39. Robertson H.A, Peterson M.R, Worth G.G Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243. Brain Res. 593:1992;332-334.
40. Rohlfs A., Nikkah G., Rosenthal C., Rundfeldt C., Brandis A., Samii M., Loscher W. Hemispheric asymmetries in spontaneous firing characteristics of substantia nigra pars reticulata neurons following a unilateral 6-hydroxydopamine lesion of the rat nigrostriatal pathway. Brain Res. 761:1997;352-356.
41. 2 dopamine receptor activation in the rat. Soc. Neurosci. Abstr. 24:1998;1647.
42. 1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703:1995;156-164.
43. Scheel-Kruger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta neurol. scand. 73(Suppl.):1986;1-50.
44. Scheel-Kruger J., Arnt J., Magelund G. Behavioral stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neurosci. Lett. 4:1977;351-356.
45. Schwarz M., Sontag K.-H., Wand P. Sensory-motor processing in substantia nigra pars reticulata in conscious cats. J. Physiol. 347:1984;129-147.
46. Setler P.E, Sarau H.M, Zirkle C.L, Saunders H.L The central effects of a novel dopamine agonist. Eur. J. Pharmac. 50:1978;419-430.
47. Sheng M., Greenberg M.E The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;447-485.
48. Twery M.J, Bergstrom D.A, Li Y.-X., Rinzel J., Walters J.R Substantia nigra pars reticulata (SNpr) neurons exhibit slow oscillations in firing rate that persist after a 6OHDA-induced lesion of midbrain dopamine neurons. Soc. Neurosci. Abstr. 22:1996;895.
49. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand. 367:1971;68-91.
50. Vallone D., Pellecchia M.T, Morelli M., Verde P., DiChiara G., Barone P. Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. Molec. Brain Res. 52:1997;307-317.
51. Walters J.R, Bergstrom D.A, Ruskin D.N, Allers K.A, Rawji S.S, Twery M.J, Kreiss D.S Relative properties of spike trains in the substantia nigra pars reticulata (SNpr) and subthalamic nucleus (STN) in an animal model of Parkinson's disease. Soc. Neurosci. Abstr. 23:1997;192.
52. Waszczak B.L, Lee E.K, Tamminga C.A, Walters J.R Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats. J. Neurosci. 4:1984;2369-2375.
53. Weick B.G, Walters J.R D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway. Neuropharmacology. 26:1987;641-644.
54. Weick B.G, Walters J.R The D-1 selective agonist SKF 38393 can activate striatal neurons in 6-hydroxydopamine lesioned rats. Soc. Neurosci. Abstr. 14:1988;1077.
55. 2 coactivation induces potentiated responses. Brain Res. 405:1987;234-246.
56. Yurek D.M, Hipkens S.B Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior. Brain Res. 639:1994;329-332.